G. Pinotti et al., CLINICAL-FEATURES, TREATMENT AND OUTCOME IN A SERIES OF 93 PATIENTS WITH LOW-GRADE GASTRIC MALT LYMPHOMA, Leukemia & lymphoma, 26(5-6), 1997, pp. 527-537
The purpose of this paper is to report the clinical characteristics an
d treatment outcome following different therapeutic approaches in a la
rge series of patients with primary low-grade MALT lymphoma of the sto
mach. A total of ninety-three patients (median age 63 years) were revi
ewed. The patients were treated by different modalities (local treatme
nt alone, combined treatment, chemotherapy, antibiotics alone); seven
patients refused any treatment. The antibiotic-treated group of patien
ts was prospectively followed with regular endoscopic biopsies, and th
eir responses were histologically evaluated. The 5-years projected ove
rall survival is 82% (95% C.I.; 67%-91%) in the series as a whole, Sec
ond tumors were observed in 21.5% of the patients in this series (95%
CI 14%v to 31%). There was no apparent difference in overall survival
and event-free survival between patients who received different treatm
ents. In the antibiotic-treated group histologic regression of MALT ly
mphoma was documented in 67% of patients (95% CI 51% to 80%). In concl
usion the indolent nature of the disease justifies a conservative appr
oach. The use of antibiotics as first-line therapy may avert or at lea
st postpone the indication for surgical resection in the majority of p
atients.